Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Long-Term Therapy with Deferasirox in Young Pediatric Patients with Transfusional Hemosiderosis Completing up to 5 Years of Treatment in the Observational E.N.T.R.U.S.T. Study

Elliott Vichinsky, Amal El-Beshlawy, Azzam Alzoebie, Annie Kamdem, MD, Suzanne Koussa, Thirachit Chotsampancharoen, Andreas Bruederle, Jackie Han, Mohsen Elalfy

Blood (2016) 128 (22): 2470.

https://doi.org/10.1182/blood.V128.22.2470.2470

Published: 2016

Journal Articles

A Phase 2 Trial Of The Fetal Hemoglobin Inducer HQK-1001 (2,2-dimethylbutyrate, Sodium Salt) In Non-Transfusion-Dependent β-Thalassemia

Adlette Inati, MD, Mario Kahale, MD, Susan P Perrine, MD, Ali T Taher, MD, Suzanne Koussa, MD, Hussein A Abbas, PhD, Therese Abi Nasr, MD, Richard G. Ghalie, MD

Blood (2013) 122 (21): 2261.

https://doi.org/10.1182/blood.V122.21.2261.2261

Published: 2013

Journal Articles

Interim Safety and Effectiveness Results From a 5-Year Observational Study of Deferasirox in Pediatric Patients Aged 2–<6 Years At Enrollment.

Elliott Vichinsky, MD, Amal El-Beshlawy, MD, Azzam Alzoebie, MD, Francoise Bernaudin, MD, Suzanne Koussa, MD, Thirachit Chotsampancharoen, MD, Ali El-Ali, MD, Caroline Arrowsmith, Nicolas Martin, MS, Mohsen El-Alfy, MD

Blood (2012) 120 (21): 2125.

https://doi.org/10.1182/blood.V120.21.2125.2125

Published: 2012

Journal Articles

Relationship Between Total Iron Removed by Phlebotomy and Iron Removed From the Liver in Pediatric Thalassemia Major Patients Following Curative Stem Cell Transplant

Adlette Inati, MD, Nada Sbeiti, MD, Ali T Taher, MD, Suzanne Koussa, MD, Timothy G St Pierre, PhD

Blood (2011) 118 (21): 5300.

https://doi.org/10.1182/blood.V118.21.5300.5300

Published: 2011

Journal Articles

1-Year Results From A Prospective Randomized Trial Comparing Phlebotomy with Deferasirox for the Treatment of Iron Overload in Pediatric Patients with Thalassemia Major Following Curative Stem Cell Transplantation

Adlette Inati, MD, Nada Sbeiti, MD, Evelyne Khoriaty, MD, M Domenica Cappellini, MD, Suzanne Koussa, MD, Therese Abi Nasr, MD, Khaled M Musallam, MD, Ali T Taher, MD

Blood (2011) 118 (21): 904.

https://doi.org/10.1182/blood.V118.21.904.904

Published: 2011

Journal Articles

HQK-1001 Is Well Tolerated and Augments Hemoglobin F and Hemoglobin Levels In Patients with Beta Thalassemia Intermedia

Suthat Fuchareon, MD, Adlette C. Inati, MD, Noppadol Siritanaratkul, MD, Suzanne Koussa, MD, Ali Taher, MD, Michael S Boosalis, PhD, Swee Lay Thein, DSc, FRCP, MB, BS, FRCPath, Wayne Wallis, MD, Patrick Bobbitt, BS, Audrey Thomson, BSc, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD

Blood (2010) 116 (21): 4280.

https://doi.org/10.1182/blood.V116.21.4280.4280

Published: 2010

Journal Articles

Iron Overload Indices In Thalassemia Major Children Cured by Stem Cell Transplantation at Enrollment In a Prospective Randomized Trial Comparing Phlebotomy and Deferasirox

Adlette C. Inati, MD, Evelyne Khoriaty, MD, Nada Sbeiti, MD, Timothy G St Pierre, PhD, Suzanne Koussa, MD, Khaled M Musallam, MD, Ali T Taher, MD

Blood (2010) 116 (21): 2082.

https://doi.org/10.1182/blood.V116.21.2082.2082

Published: 2010

Journal Articles

Brain MRI Findings in Lebanese Sickle Cell Disease Patients.

Adlette Inati, MD, Youssef Rachkidi, MD, Ossama Jradi, MD, Rabih Wehbe, MD, Habib Moallem, PhD, Suzanne Koussa, MD, Ali Taher, MD

Blood (2007) 110 (11): 3794.

https://doi.org/10.1182/blood.V110.11.3794.3794

Published: 2007

Journal Articles

Study on Hepatitis C Treatment Using Ribavirin and Pegylated Interferon in Thalassemia Patients (SCRIPT): One Year Report.

Adlette Inati, MD, Ala Sharara, MD, Sandy Ghorra, PharmD, Elie Aoun, MD, Marwan Taha, PharmD, Suzanne Koussa, MD, Ali Taher, MD.

Blood (2004) 104 (11): 3768.

https://doi.org/10.1182/blood.V104.11.3768.3768

Published: 2004

NARROW

Long-Term Therapy with Deferasirox in Young Pediatric Patients with Transfusional Hemosiderosis Completing up to 5 Years of Treatment in the Observational E.N.T.R.U.S.T. Study

A Phase 2 Trial Of The Fetal Hemoglobin Inducer HQK-1001 (2,2-dimethylbutyrate, Sodium Salt) In Non-Transfusion-Dependent β-Thalassemia

Interim Safety and Effectiveness Results From a 5-Year Observational Study of Deferasirox in Pediatric Patients Aged 2–<6 Years At Enrollment.

Relationship Between Total Iron Removed by Phlebotomy and Iron Removed From the Liver in Pediatric Thalassemia Major Patients Following Curative Stem Cell Transplant

1-Year Results From A Prospective Randomized Trial Comparing Phlebotomy with Deferasirox for the Treatment of Iron Overload in Pediatric Patients with Thalassemia Major Following Curative Stem Cell Transplantation

HQK-1001 Is Well Tolerated and Augments Hemoglobin F and Hemoglobin Levels In Patients with Beta Thalassemia Intermedia

Iron Overload Indices In Thalassemia Major Children Cured by Stem Cell Transplantation at Enrollment In a Prospective Randomized Trial Comparing Phlebotomy and Deferasirox

Brain MRI Findings in Lebanese Sickle Cell Disease Patients.

Study on Hepatitis C Treatment Using Ribavirin and Pegylated Interferon in Thalassemia Patients (SCRIPT): One Year Report.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only